Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,923JPY
23 Apr 2018
Change (% chg)

¥66 (+1.36%)
Prev Close
¥4,857
Open
¥4,854
Day's High
¥4,935
Day's Low
¥4,795
Volume
5,821,900
Avg. Vol
2,502,257
52-wk High
¥6,693
52-wk Low
¥4,795

Select another date:

Fri, Apr 20 2018

Photo

Japan's Takeda sweetens $62 billion Shire offer

TOKYO/LONDON Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. | Video

UPDATE 4-Japan's Takeda sweetens $62 billion Shire offer

* Takeda makes fourth cash and shares bid at 47-pounds-a-share

BRIEF-Shire Says Considering Position With Respect To Fourth Proposal From Takeda

* SHIRE PLC - STATEMENT RE PROPOSAL FROM TAKEDA PHARMACEUTICAL COMPANY LIMITED ("TAKEDA")

Takeda weighs raising Shire bid to more than 47 stg/share: sources

Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

Takeda weighs raising Shire bid to more than 47 stg/share-sources

April 20 Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

Shire rejects $63 billion Takeda bid as Allergan drops pursuit

NEW YORK/LONDON Rare disease drug maker Shire Plc said on Thursday it had rejected a $63 billion cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd , while Allergan Plc reversed course on pursuing a rival bid.

Deals of the day-Mergers and acquisitions

April 19 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Rare disease drug maker Shire Plc said it had rejected a $63 billion cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd, while Allergan Plc reversed course on pursuing a rival bid. ** Austrian property group Immofinanz is putting its 26 percent stake in peer CA Immo on the block, it said, after a review of its strategic options.

UPDATE 5-Shire rejects $63 bln Takeda bid as Allergan drops pursuit

* Shire takeover fights follows surge in drug sector M&A (Adds new Allergan statement)

Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources

Botox maker Allergan Plc is in talks to acquire Shire Plc, competing against Japan's Takeda Pharmaceutical Co Ltd for the London-listed drugmaker, two sources familiar with the matter said on Thursday.

Takeda makes $61 billion bid for drugmaker Shire: sources

LONDON Takeda Pharmaceutical has made a bid for Shire that values the London-listed drugmaker at around $61 billion, two sources with direct knowledge of the matter told Reuters.

Select another date: